Responders to Low-Dose ATG Induce CD4 T Cell Exhaustion in Type 1 Diabetes

Treatment with low-dose anti-thymocyte globulin (ATG) preserved Tregs, as measured by stable methylation of FOXP3 Treg-specific demethylation region and increased proportions of CD4+FOXP3+ Tregs identified by flow cytometry.